defa14a
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o   Preliminary Proxy Statement
 
o   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 
o   Definitive Proxy Statement
 
þ   Definitive Additional Materials
 
o   Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
MEDICIS PHARMACEUTICAL CORPORATION
 
(Name of Registrant as Specified in its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
     þ No fee required.
     o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
     (1) Title of each class of securities to which transaction applies:
 
     (2) Aggregate number of securities to which transaction applies:
 
  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
 
     (4) Proposed maximum aggregate value of transaction:
 
     (5) Total fee paid:
 
     o Fee paid previously with preliminary materials.
 
     o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
     (1) Amount Previously Paid:
 
     (2) Form, Schedule or Registration Statement No.:
 
     (3) Filing Party:
 
     (4) Date Filed:

 

       
       
       
      COMPANY #            
       
      CONTROL #            
       
       
       
 
MEDICIS PHARMACEUTICAL CORPORATION
8125 North Hayden Road
Scottsdale, Arizona 85258
2008 ANNUAL MEETING OF STOCKHOLDERS
 
Notice is hereby given that the 2008 Annual Meeting of Stockholders of Medicis Pharmaceutical Corporation will be held at the Hyatt Regency Scottsdale Resort and Spa at Gainey Ranch, 7500 East Doubletree Ranch Road, Scottsdale, Arizona on Tuesday, May 20, 2008 at 9:30 a.m. local time.
 
Directions to the Annual Meeting can be viewed at www.ematerials.com/mrx.
 
Important Notice Regarding the Availability of Proxy Materials for the
2008 Stockholder Meeting to be Held on May 20, 2008
 
  1.   This communication presents an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.
 
  2.   The Proxy Statement for the 2008 Annual Meeting, and the Annual Report for our fiscal year ended December 31, 2007 are available at www.ematerials.com/mrx.
 
  3.   If you want to receive a paper or e-mail copy of these documents, you must request one. There is no charge to you for requesting a copy. Please make your request for a copy as instructed below on or before May 8, 2008 to facilitate timely delivery.
 
Matters intended to be acted upon at the Annual Meeting are listed below.
 
  1.   The re-election of the following three director nominees, as described under Item 1 of the Proxy Statement.
 
1.  Spencer Davidson
 
2.  Stuart Diamond
 
3.  Peter S. Knight, Esq.
 
  2.   The ratification of the selection of Ernst and Young LLP as independent auditors of Medicis for the fiscal year ending December 31, 2008, as described under Item 2 of the Proxy Statement.
 
The Board of Directors recommends that you vote “FOR” the re-election of the three director nominees and “FOR” the ratification of Ernst and Young LLP as independent auditors of Medicis for the fiscal year ending December 31, 2008.
 
You may immediately
vote your proxy on the Internet at:
www.eproxy.com/mrx
 
  •   Use the Internet to vote your proxy 24 hours a day, 7 days a week, until 11:59 p.m. (EDT) on May 19, 2008.
 
  •   Please have this Notice and the last four digits of you Social Security Number or Tax Identification Number available. Follow the online instructions to vote your proxy.
 
  •   Your Internet vote authorizes the proxies designated by the Board of Directors to vote your shares in the same manner as if you marked, signed and returned a proxy card.

 

To request paper or electronic copies of the proxy materials, which include the
proxy card, Proxy Statement and Annual Report, please contact us via:
 
Internet – Access the Internet and go to www.ematerials.com/mrx. Follow the instructions on the website to log in and order copies. If you would like this election to apply to delivery of material for all future meetings, please have the last four digits of your Social Security Number or Tax Identification Number available and follow the instructions on the website.
 
Telephone – Call us free of charge at (866) 697-9377 in the U.S. or Canada, using a touch-tone phone, and follow the instructions to order copies. If you would like this election to apply to delivery of material for all future meetings, please have the last four digits of your Social Security Number or Tax Identification Number available and follow the automated instructions.
 
Email – Send us an email at EP@ematerials.com with “MRX Materials Request” in the subject line. The email must include:
 
  •   The 3-digit company # and the 11-digit control # located in the box in the upper right hand corner of this notice.
 
  •   Your preference to receive printed materials via mail – or – to receive an email with links to the electronic materials.
 
  •   If you choose email delivery, you must include the email address that you would like the links to the electronic materials sent. Your email address will not be used for any purpose other than to send a copy of the proxy materials to you.
 
  •   If you would like this election to apply to delivery of material for all future meetings, write the word “Permanent” and include the last 4 digits of your Social Security Number or Tax Identification Number in the email.